Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs.

Saved in:
Bibliographic Details
Title: Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs.
Authors: Wei BR; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States., Peer CJ; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States., Richardson WJ; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States., Hewitt SM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States., Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States., Simpson RM; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
Source: Frontiers in veterinary science [Front Vet Sci] 2022 Dec 14; Vol. 9, pp. 1056408. Date of Electronic Publication: 2022 Dec 14 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101666658 Publication Model: eCollection Cited Medium: Print ISSN: 2297-1769 (Print) Linking ISSN: 22971769 NLM ISO Abbreviation: Front Vet Sci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36590793
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wei+BR%22">Wei BR</searchLink>; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD, United States.<br /><searchLink fieldCode="AU" term="%22Peer+CJ%22">Peer CJ</searchLink>; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Richardson+WJ%22">Richardson WJ</searchLink>; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Hewitt+SM%22">Hewitt SM</searchLink>; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Figg+WD%22">Figg WD</searchLink>; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.<br /><searchLink fieldCode="AU" term="%22Simpson+RM%22">Simpson RM</searchLink>; Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101666658%22">Frontiers in veterinary science</searchLink> [Front Vet Sci] 2022 Dec 14; Vol. 9, pp. 1056408. <i>Date of Electronic Publication: </i>2022 Dec 14 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101666658 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2297-1769 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222971769%22">22971769 </searchLink><i>NLM ISO Abbreviation: </i>Front Vet Sci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36590793
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fvets.2022.1056408
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1056408
    Titles:
      – TitleFull: Pharmacokinetics and tolerability of the dual TORC1/2 inhibitor sapanisertib in combination with the MEK inhibitor trametinib in dogs.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wei BR
      – PersonEntity:
          Name:
            NameFull: Peer CJ
      – PersonEntity:
          Name:
            NameFull: Richardson WJ
      – PersonEntity:
          Name:
            NameFull: Hewitt SM
      – PersonEntity:
          Name:
            NameFull: Figg WD
      – PersonEntity:
          Name:
            NameFull: Simpson RM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 14
              M: 12
              Text: 2022 Dec 14
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2297-1769
          Numbering:
            – Type: volume
              Value: 9
          Titles:
            – TitleFull: Frontiers in veterinary science
              Type: main
ResultId 1